Literature DB >> 12006472

Common features in the onset of ARDS after administration of granulocyte colony-stimulating factor.

Hiroyuki Takatsuka1, Yoshinobu Takemoto, Ako Mori, Takahiro Okamoto, Akihisa Kanamaru, Eizo Kakishita.   

Abstract

STUDY
OBJECTIVE: Respiratory disturbance caused by ARDS has been reported during administration of granulocyte-colony stimulating factor. The clinical features of such respiratory distress were investigated in this study.
DESIGN: Retrospective case review.
SETTING: A 1,100-bed university teaching hospital. PATIENTS: Five patients who had dyspnea caused by ARDS develop after chemotherapy or bone marrow transplantation (BMT) at our hospital.
INTERVENTIONS: None. MEASUREMENTS AND
RESULTS: Levels of cytokines, human leukocyte antigen (HLA) typing, and the clinical course were analyzed to clarify common features. All five patients possessed HLA-B51 or HLA-B52, and all had fever and an enhanced inflammatory response at the time of the WBC nadir. The tumor necrosis factor (TNF)-alpha and interleukin (IL)-8 levels increased when respiratory distress syndrome occurred.
CONCLUSIONS: If patients with HLA-B51 or HLA-B52 have infection develop at the time of WBC nadir after chemotherapy or BMT, ARDS may occur in association with elevation of TNF-alpha and IL-8 during WBC recovery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12006472     DOI: 10.1378/chest.121.5.1716

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

1.  Severe Hypoxemia in a Healthy Donor for Allogeneic Hematopoietic Stem Cell Transplantation after Only the First Administration of Granulocyte-Colony Stimulating Factor.

Authors:  Keita Yamamoto; Noriko Doki; Yasushi Senoo; Yuho Najima; Takeshi Kobayashi; Kazuhiko Kakihana; Kyoko Haraguchi; Yoshiki Okuyama; Hisashi Sakamaki; Kazuteru Ohashi
Journal:  Transfus Med Hemother       Date:  2016-10-18       Impact factor: 3.747

2.  Pleomorphic carcinoma of the lung producing granulocyte colony-stimulating factor: report of a case.

Authors:  Hironobu Wada; Shigetoshi Yoshida; Fumihiro Ishibashi; Teruaki Mizobuchi; Yasumitsu Moriya; Hidehisa Hoshino; Tatsuro Okamoto; Makoto Suzuki; Kiyoshi Shibuya; Ichiro Yoshino
Journal:  Surg Today       Date:  2011-07-20       Impact factor: 2.549

3.  Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies.

Authors:  Chin Kook Rhee; Ji Young Kang; Yong Hyun Kim; Jin Woo Kim; Hyung Kyu Yoon; Seok Chan Kim; Soon Suk Kwon; Young Kyoon Kim; Kwan Hyung Kim; Hwa Sik Moon; Sung Hak Park; Hee Je Kim; Seok Lee; Jeong Sup Song
Journal:  Crit Care       Date:  2009-11-03       Impact factor: 9.097

4.  Plasma granulocyte colony-stimulating factor levels correlate with clinical outcomes in patients with acute lung injury.

Authors:  Benjamin T Suratt; Mark D Eisner; Carolyn S Calfee; Jenna B Allard; Laurie A Whittaker; Dustin T Engelken; Joseph M Petty; Thomas Trimarchi; Lauren Gauthier; Polly E Parsons
Journal:  Crit Care Med       Date:  2009-04       Impact factor: 7.598

5.  Granulocyte colony-stimulating factor blockade enables dexamethasone to inhibit lipopolysaccharide-induced murine lung neutrophils.

Authors:  Jesus Banuelos; Yun Cao; Soon Cheon Shin; Bruce S Bochner; Pedro Avila; Shihong Li; Xin Jiang; Mark W Lingen; Robert P Schleimer; Nick Z Lu
Journal:  PLoS One       Date:  2017-05-19       Impact factor: 3.240

6.  Personalized cancer supportive care in COVID-19 era.

Authors:  G H Lyman; N M Kuderer
Journal:  Ann Oncol       Date:  2020-05-13       Impact factor: 32.976

7.  Respiratory status deterioration during G-CSF-induced neutropenia recovery.

Authors:  L Karlin; M Darmon; G Thiéry; M Ciroldi; S de Miranda; A Lefebvre; B Schlemmer; E Azoulay
Journal:  Bone Marrow Transplant       Date:  2005-08       Impact factor: 5.483

Review 8.  Side effects of cytokines approved for therapy.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606

Review 9.  How the SARS coronavirus causes disease: host or organism?

Authors:  Anthony W I Lo; Nelson L S Tang; Ka-Fai To
Journal:  J Pathol       Date:  2006-01       Impact factor: 7.996

10.  G-CSF and GM-CSF Are Different. Which One Is Better for COVID-19?

Authors:  Hillard M Lazarus; Robert Peter Gale
Journal:  Acta Haematol       Date:  2020-08-13       Impact factor: 2.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.